Published on June 6, 2019
The GRC n°21 Alzheimer Precision Medicine works on the evidence of biomarkers (imaging, fluids) that will help at defining and characterizing the earliest stages of Alzheimer’s disease. Amongst this team, a subproject aims at identifying the factors of vulnerability of brain networks in the course of Alzheimer’s disease using longitudinal multimodal neuroimaging data. This is based on the analysis of neuroimaging data of the INSIGHT cohort.
The GRC is looking for an engineer / software developer for the inalysis of multimodal longitudinal neuroimaging data in Alzheimer’s disease.